The new powder formulation gives children and adults living with Rett syndrome greater flexibility and choice in dose volume and taste
Implementing PFAS testing in the early development stages allows medical device manufacturers to prepare for potential regulatory updates
Despite steep funding setbacks, the global HIV response has gained momentum in 2025 with the introduction of twice-yearly injectable LEN
A key highlight will be Brenntag’s qualified amino acids portfolio
Elevidys came under scrutiny in June when the FDA disclosed two fatal cases in non-ambulatory boys who developed dangerously high liver enzyme levels
The partnership combines Croda’s deep expertise in smart science and global market reach with Amino’s advanced capabilities in precision manufacturing of amino acids
The approvals target adult MIBC patients who are ineligible for cisplatin-based chemotherapy
The licence covers Actimed’s existing patents, its proprietary know-how and any future related patents, giving Mankind full control to advance the products under its own brands
Total income for the period stood at Rs. 7101.28 crore
ALBIS will present a selection of advanced materials from its broad healthcare portfolio
Subscribe To Our Newsletter & Stay Updated
